参松养心胶囊联合倍他乐克治疗室性早搏的临床疗效观察

发布时间：2019-07-08 20:52

【摘要】：目的探讨参松养心胶囊(人参、麦冬、南五味子等)联合倍他乐克(酒石酸美托洛尔)对室性早搏的的临床疗效。方法选取菏泽市中医医院心血管内科(住院部和门诊)2012年1月至2015年1月符合室性早搏诊断纳入标准的患者76例,采用随机数字表随机分为治疗组和对照组(每组各38例),对照组给予倍他乐克治疗,治疗组采取参松养心胶囊加用倍他乐克联合治疗。治疗后,监测两组患者的动态心电图(Holter),观察早搏总数、临床症状改善情况、中医证候积分及倍他乐克停用情况。结果治疗组与对照组患者早搏总数均明显减少,但治疗组患者室性早搏次数减少较多,两组在治疗后早搏总数仍存在差异,治疗组早搏次数少于对照组;治疗组患者的临床症状有效率为(94.7%),较对照组(71.4%)明显提高;治疗组患者的中医证候积分有效率为(84.2%),较对照组(63.2%)明显提高;加用参松养心胶囊4周后,治疗组组内治疗后较治疗前倍他乐克用量明显减少,对照组治疗后较治疗前倍他乐克用量也存在差异,但治疗组差异更加显著。结论参松养心胶囊与倍他乐克联合治疗室性早搏,可有效控制室性早搏,减轻患者临床症状,疗效确切。
[Abstract]:Objective to investigate the clinical effect of Shensong Yangxin capsule (ginseng, Ophiopogon japonicus, Schisandra chinensis, etc.) combined with metoprolol tartrate on ventricular premature beat. Methods from January 2012 to January 2015, 76 patients in Department of Cardiovascular Medicine (inpatient Department and outpatient Department) of Heze City Hospital of traditional Chinese Medicine were randomly divided into treatment group and control group (38 cases in each group). The control group was treated with betaloc, and the treatment group was treated with Shensong Yangxin capsule combined with betaloc. After treatment, the total number of premature beats, the improvement of clinical symptoms, the score of TCM syndromes and the discontinuation of betaloc were observed by dynamic electrocardiogram (Holter),) in the two groups. Results the total number of premature beats in the treatment group and the control group was significantly decreased, but the number of ventricular premature beats in the treatment group was more than that in the control group, and there was still difference in the total number of premature beats between the two groups after treatment, the number of premature beats in the treatment group was less than that in the control group, and the effective rate of clinical symptoms in the treatment group was 94.7%, which was significantly higher than that in the control group (71.4%). The effective rate of TCM syndrome score in the treatment group was 84.2%, which was significantly higher than that in the control group (63.2%). After 4 weeks of administration of Shensong Yangxin capsule, the dosage of betaloc in the treatment group was significantly lower than that before treatment, and the dosage of betaloc in the control group was also different from that before treatment, but the difference in the treatment group was more significant. Conclusion the combination of Shensong Yangxin capsule and betaloc in the treatment of ventricular premature beat can effectively control ventricular premature beat and alleviate the clinical symptoms of the patients, and the curative effect is accurate.
【作者单位】：山东省菏泽市中医医院;南方医科大学;
【分类号】：R541.7

【相似文献】